Sarah M.

Sarah M. began their work experience in 2001 at Kosan Biosciences, Inc. as a Senior Scientist, leading a multidisciplinary oncology research project. Sarah then joined Nivalis Therapeutics, Inc. in 2008, where they held various roles, ultimately becoming the Director of Clinical and Translational Research. In 2017, they worked as a Contractor for Independent Biotechnology Consultant before transitioning to the role of Executive Director of Clinical Science at Celcuity.

Sarah M. holds a B.S. in Microbiology from Indiana University Bloomington and a Ph.D. in Biochemistry from the University of California, San Francisco. Sarah also obtained certifications in Pediatric Drug Development & Clinical Trials from Symmetric Training and ICH GCP E6 (R2) Good Clinical Practice for Sponsors and CROs from Barnett International in 2022.